JP5027310B2 - タンパク質の逆圧濾過 - Google Patents

タンパク質の逆圧濾過 Download PDF

Info

Publication number
JP5027310B2
JP5027310B2 JP2010540839A JP2010540839A JP5027310B2 JP 5027310 B2 JP5027310 B2 JP 5027310B2 JP 2010540839 A JP2010540839 A JP 2010540839A JP 2010540839 A JP2010540839 A JP 2010540839A JP 5027310 B2 JP5027310 B2 JP 5027310B2
Authority
JP
Japan
Prior art keywords
pressure
filtrate
filter
protein
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010540839A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507962A5 (enExample
JP2011507962A (ja
Inventor
ネボイザ ニコリク，
ミカエラ フレイ，
ウォルフガング グラブマイアー，
トーマス ヤンツィク，
マティアス フリード，
クラウス ツシェツシュコウィッシュ，
クルト シュネッカー，
バーバラ リーグラー，
アルマ カサポヴィック，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40602549&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5027310(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of JP2011507962A publication Critical patent/JP2011507962A/ja
Publication of JP2011507962A5 publication Critical patent/JP2011507962A5/ja
Application granted granted Critical
Publication of JP5027310B2 publication Critical patent/JP5027310B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2010540839A 2007-12-28 2008-12-22 タンパク質の逆圧濾過 Active JP5027310B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1741807P 2007-12-28 2007-12-28
US61/017,418 2007-12-28
PCT/US2008/088005 WO2009086296A2 (en) 2007-12-28 2008-12-22 Counter-pressure filtration of proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012105696A Division JP5466263B2 (ja) 2007-12-28 2012-05-07 タンパク質の逆圧濾過

Publications (3)

Publication Number Publication Date
JP2011507962A JP2011507962A (ja) 2011-03-10
JP2011507962A5 JP2011507962A5 (enExample) 2012-02-02
JP5027310B2 true JP5027310B2 (ja) 2012-09-19

Family

ID=40602549

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2010540839A Active JP5027310B2 (ja) 2007-12-28 2008-12-22 タンパク質の逆圧濾過
JP2012105696A Active JP5466263B2 (ja) 2007-12-28 2012-05-07 タンパク質の逆圧濾過
JP2014009986A Active JP5925817B2 (ja) 2007-12-28 2014-01-23 タンパク質の逆圧濾過
JP2016040641A Pending JP2016106131A (ja) 2007-12-28 2016-03-03 タンパク質の逆圧濾過

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2012105696A Active JP5466263B2 (ja) 2007-12-28 2012-05-07 タンパク質の逆圧濾過
JP2014009986A Active JP5925817B2 (ja) 2007-12-28 2014-01-23 タンパク質の逆圧濾過
JP2016040641A Pending JP2016106131A (ja) 2007-12-28 2016-03-03 タンパク質の逆圧濾過

Country Status (18)

Country Link
US (4) US7959809B2 (enExample)
EP (2) EP2242479B1 (enExample)
JP (4) JP5027310B2 (enExample)
KR (3) KR101839278B1 (enExample)
CN (1) CN101909599B (enExample)
AR (2) AR070061A1 (enExample)
AT (1) ATE525062T1 (enExample)
AU (1) AU2008345218B2 (enExample)
CA (1) CA2709781C (enExample)
DK (1) DK2242479T3 (enExample)
ES (1) ES2377038T3 (enExample)
HR (1) HRP20110927T1 (enExample)
NZ (2) NZ600053A (enExample)
PL (1) PL2242479T3 (enExample)
PT (1) PT2242479E (enExample)
SG (1) SG187411A1 (enExample)
SI (1) SI2242479T1 (enExample)
WO (1) WO2009086296A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014166989A (ja) * 2007-12-28 2014-09-11 Baxter Internatl Inc タンパク質の逆圧濾過

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI469992B (zh) 2008-08-28 2015-01-21 Baxter Int 濃縮剪切靈敏生物聚合物的方法
US10100594B2 (en) * 2013-06-27 2018-10-16 Ge Oil & Gas Uk Limited Control system and a method for monitoring a filter in an underwater hydrocarbon well
WO2015107214A1 (en) * 2014-01-20 2015-07-23 Eveon Process for reconstitution of a solid form of a pharmaceutical composition

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
US5047154A (en) * 1983-03-10 1991-09-10 C.P.C. Engineering Company Method and apparatus for enhancing the flux rate of cross-flow filtration systems
SE443075B (sv) * 1984-06-01 1986-02-17 Alfa Laval Agri Int Forfarande och anordning for framstellning av mjolkkoncentrat genom membranfiltrering
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
DE3730868A1 (de) 1987-09-15 1989-03-23 Henkel Kgaa Verfahren zur abtrennung von biotechnisch hergestellten wertstoffen aus einer fermenterbruehe durch querstrom-mikro- und/oder ultrafiltration
SE9003452L (sv) 1990-10-30 1992-05-01 Teinvall Sjoeberg & Broberg Ab Saett och anordning vid vaetskefiltrering
CH687055A5 (de) * 1993-12-03 1996-09-13 Bucher Guyer Ag Masch Verfahren und Vorrichtung zum Eindicken von Fest/Fluessig-Gemischen mittels Membrantechnologie.
US5525144A (en) * 1995-04-20 1996-06-11 A/G Technology Corporation Tangential flow filtering and separating
AT403764B (de) * 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
ES2149515T3 (es) * 1996-07-10 2000-11-01 American Nat Red Cross Metodos para la separacion selectiva de componentes organicos a partir de fluidos biologicos.
US5888401A (en) * 1996-09-16 1999-03-30 Union Camp Corporation Method and apparatus for reducing membrane fouling
AT406867B (de) * 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
US5947689A (en) * 1997-05-07 1999-09-07 Scilog, Inc. Automated, quantitative, system for filtration of liquids having a pump controller
FR2772381B1 (fr) 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
US6139878A (en) 1998-04-27 2000-10-31 Aventis Behring, Llc Method for preparing a diafiltered stabilized blood product
JP4216478B2 (ja) * 1998-09-21 2009-01-28 パーダム、ハワード・イー 感温性の材料を処理する方法および装置
DE19964370B4 (de) * 1999-02-16 2006-05-11 Huss, Manfred Herstellung eines geschäumten Molkenproteinprodukts
US6623781B2 (en) 1999-07-26 2003-09-23 Cornell Research Foundation, Inc. Microfiltration of skim milk for cheese making and whey proteins
US6485762B1 (en) * 1999-07-26 2002-11-26 Cornell Research Foundation, Inc. Microfiltration of skim milk for cheese making and whey proteins
DE10211227A1 (de) * 2002-03-13 2003-10-02 Aventis Behring Gmbh Verfahren zur Rekonstitution von Iyophilisierten Proteinen
SE522048C2 (sv) 2002-05-17 2004-01-07 Hemapure Ab Anordning och system för filtrering av blod
US7439013B2 (en) * 2002-06-17 2008-10-21 Asahi Kasei Kuraray Medical Co., Ltd. Biocompatible polymer and filter for selectively eliminating leucocytes using the same
ES2214967B1 (es) 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
CA2535489C (en) * 2003-08-14 2014-09-30 D. Collen Research Foundation Vzw Antibodies against factor viii with modified glycosylation in the variable region
FR2861395B1 (fr) * 2003-10-23 2006-02-17 Lab Francais Du Fractionnement Facteur viii viralement securise a faible teneur en multimeres superieurs
ES2317517T5 (es) * 2005-04-11 2016-01-21 Crucell Holland B.V. Purificación de virus usando ultrafiltración
ES2377038T3 (es) * 2007-12-28 2012-03-21 Baxter International Inc. Filtración de proteínas a contra-presión

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014166989A (ja) * 2007-12-28 2014-09-11 Baxter Internatl Inc タンパク質の逆圧濾過

Also Published As

Publication number Publication date
AU2008345218B2 (en) 2015-02-19
CN101909599B (zh) 2012-11-21
HK1150750A1 (en) 2012-01-13
KR20100106485A (ko) 2010-10-01
DK2242479T3 (da) 2012-01-02
BRPI0821599A2 (pt) 2015-06-16
KR101748878B1 (ko) 2017-06-19
PT2242479E (pt) 2011-11-25
SG187411A1 (en) 2013-02-28
KR20170070255A (ko) 2017-06-21
US20120136139A1 (en) 2012-05-31
PL2242479T3 (pl) 2012-02-29
JP2016106131A (ja) 2016-06-16
KR20180028559A (ko) 2018-03-16
NZ600053A (en) 2013-06-28
JP5466263B2 (ja) 2014-04-09
AR116112A2 (es) 2021-03-31
EP2242479B1 (en) 2011-09-21
ES2377038T3 (es) 2012-03-21
KR101915445B1 (ko) 2018-11-05
CA2709781C (en) 2017-03-14
CN101909599A (zh) 2010-12-08
KR101839278B1 (ko) 2018-03-15
US7959809B2 (en) 2011-06-14
ATE525062T1 (de) 2011-10-15
JP2012144578A (ja) 2012-08-02
EP2242479A2 (en) 2010-10-27
CA2709781A1 (en) 2009-07-09
JP5925817B2 (ja) 2016-05-25
US20100317081A1 (en) 2010-12-16
SI2242479T1 (sl) 2012-01-31
WO2009086296A3 (en) 2009-08-27
US8075782B2 (en) 2011-12-13
NZ586316A (en) 2012-06-29
HRP20110927T1 (hr) 2012-02-29
WO2009086296A2 (en) 2009-07-09
AU2008345218A1 (en) 2009-07-09
JP2014166989A (ja) 2014-09-11
US20100314317A1 (en) 2010-12-16
US8075781B2 (en) 2011-12-13
EP2392317A1 (en) 2011-12-07
JP2011507962A (ja) 2011-03-10
US8454833B2 (en) 2013-06-04
US20090188862A1 (en) 2009-07-30
AR070061A1 (es) 2010-03-10

Similar Documents

Publication Publication Date Title
US7919592B2 (en) Method for separating off viruses from a protein solution by means of nanofiltration
JP5925817B2 (ja) タンパク質の逆圧濾過
EP1161958A1 (en) A method for the inactivation of viruses in biological liquids
US20150152162A1 (en) Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the same
AU2015202699B2 (en) Counter-Pressure Filtration of Proteins
HK1150750B (en) Counter-pressure filtration of proteins
BRPI0821599B1 (pt) Métodos de filtração de uma mistura líquida de proteína
US6074560A (en) Use of an in-line filter in the preparation of total nutrient admixtures
WO2025040552A1 (en) Method for sterile filtration of aqueous solutions containing albumin

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111207

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111207

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20111207

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20111228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120112

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120411

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120507

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120531

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120621

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150629

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5027310

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250